We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.28%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$15.4B
AUM Growth
+$3.25B
Cap. Flow
+$3.84B
Cap. Flow %
24.9%
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$246M
2
MSFT icon
Microsoft
MSFT
+$216M
3
AMZN icon
Amazon
AMZN
+$130M
4
TSLA icon
Tesla
TSLA
+$79.6M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$73.3M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 12.21%
3 Financials 12.1%
4 Consumer Discretionary 11.41%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THRY icon
2501
Thryv Holdings
THRY
$93.3M
$154K ﹤0.01%
5,474
+1,958
+56% +$61.4K
PSTL
2502
Postal Realty Trust
PSTL
$713M
$153K ﹤0.01%
+9,117
New +$162K
CTRN icon
2503
Citi Trends
CTRN
$626M
$153K ﹤0.01%
5,006
+1,564
+45% +$73.1K
CELL
2504
DELISTED
PhenomeX Inc. Common Stock
CELL
$153K ﹤0.01%
21,559
+4,199
+24% +$34.7K
PPLI
2505
People Inc
PPLI
$2.99B
$153K ﹤0.01%
+1,863
New +$181K
IPSC icon
2506
Century Therapeutics
IPSC
$359M
$153K ﹤0.01%
+12,167
New +$161K
ATOM icon
2507
Atomera
ATOM
$215M
$153K ﹤0.01%
11,721
+4,195
+56% +$62.8K
AUD
2508
DELISTED
Audacy, Inc.
AUD
$153K ﹤0.01%
52,952
+40,213
+316% +$106K
JANX icon
2509
Janux Therapeutics
JANX
$994M
$152K ﹤0.01%
10,614
+5,312
+100% +$86.9K
ITIC
2510
Investors Title Co
ITIC
$526M
$152K ﹤0.01%
747
+271
+57% +$54K
NRIM icon
2511
Northrim BanCorp
NRIM
$602M
$152K ﹤0.01%
13,936
+5,060
+57% +$56K
RRGB icon
2512
Red Robin
RRGB
$187M
$151K ﹤0.01%
8,965
+7,043
+366% +$114K
NESR
2513
National Energy Services Reunited Corp
NESR
$3.57B
$151K ﹤0.01%
17,959
+6,628
+58% +$63.1K
BHR
2514
Braemar Hotels & Resorts
BHR
$140M
$151K ﹤0.01%
24,401
+22,716
+1,348% +$130K
MLR icon
2515
Miller Industries
MLR
$635M
$150K ﹤0.01%
5,337
+2,032
+61% +$62.6K
ORMP icon
2516
Oramed Pharmaceuticals
ORMP
$184M
$150K ﹤0.01%
17,360
+6,407
+58% +$65.6K
CVLG icon
2517
Covenant Logistics
CVLG
$885M
$149K ﹤0.01%
13,848
+5,028
+57% +$56.5K
BRT
2518
BRT Apartments
BRT
$270M
$149K ﹤0.01%
+6,210
New +$140K
NCNO icon
2519
nCino
NCNO
$2.09B
$149K ﹤0.01%
+3,630
New +$166K
COLD icon
2520
Americold
COLD
$4.34B
$149K ﹤0.01%
+5,331
New +$150K
LSXMK
2521
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$146K ﹤0.01%
+4,125
New +$153K
PRTY
2522
DELISTED
Party City Holdco Inc.
PRTY
$146K ﹤0.01%
40,806
+1,689
+4% +$7.64K
GBIO
2523
DELISTED
Generation Bio
GBIO
$145K ﹤0.01%
1,979
+1,636
+477% +$94.8K
PKE icon
2524
Park Aerospace
PKE
$806M
$144K ﹤0.01%
11,062
+3,937
+55% +$52.9K
EVC icon
2525
Entravision Communication
EVC
$852M
$144K ﹤0.01%
22,423
+753
+3% +$4.68K

Similar funds

MetLife Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.

  • MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
  • MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
  • MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
  • MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
  • MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
  • MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.